ADIPOQ and fetal growth restriction: Maternal docosahexaenoic acid increased adiponectin and normalized intrauterine growth restriction-induced changes in rat adipose deposition, thereby suggesting usefulness of the acid in treating adipose dysfunction or in improving metabolic function [42].